{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:47:33Z","timestamp":1779234453530,"version":"3.51.4"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The impact of delayed diagnosis on tumor-related prognosis appears to be minimal in individuals with intracranial germ cell tumors (iGCTs). However, its effect on neuroendocrine functions remains unclear. We aimed to assess the effects of delayed diagnosis on neuroendocrine function in individuals with suprasellar GCTs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective cohort study of 459 individuals with suprasellar GCTs and categorized them into two groups based on disease duration: delayed diagnosis (&amp;gt; 6 months) and non-delayed diagnosis (\u2264 6 months). We compared endocrinological symptoms, neuroendocrine dysfunction and its grading (categorized into 0\u20133 grades based on severity), and recovery from neuroendocrine dysfunction in both groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with delayed diagnosis exhibited higher incidences of amenorrhea, slow growth, fatigue, and polyuria\/polydipsia. Neuroendocrine dysfunction, including central adrenal insufficiency (CAI), central hypothyroidism (CHT), arginine vasopressin deficiency (AVP-D), growth hormone deficiency, hypogonadism, and hyperprolactinemia, was more pronounced in the delayed diagnosis group at diagnosis, the end of treatment, and the last follow-up. Furthermore, individuals with delayed diagnosis showed higher grades of neuroendocrine dysfunction at diagnosis (OR=3.005, 95% CI 1.929\u20134.845, p&amp;lt;0.001), end of oncologic treatment (OR=4.802, 95% CI 2.878\u20138.004, p&amp;lt;0.001), and last follow-up(OR=2.335, 95% CI 1.307\u20134.170, p=0.005) after adjusting for confounders. Finally, less recovery, particularly in CAI, CHT, and AVP-D, was seen among the group with delayed diagnosis after treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Among individuals with suprasellar GCTs, delayed diagnosis is associated with increased, more severe, and less recovered neuroendocrine dysfunction, emphasizing the importance of early diagnosis and treatment to reduce neuroendocrine dysfunction.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1408065","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T05:12:43Z","timestamp":1718687563000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of delayed diagnosis on neuroendocrine function in individuals with suprasellar germ cell tumors"],"prefix":"10.3389","volume":"15","author":[{"given":"Tao","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470\u20132045(15)00244\u20132","article-title":"Consensus on the management of intracranial germ-cell tumours","volume":"16","author":"Murray","year":"2015","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2013.333","article-title":"Highlights from the third international central nervous system germ cell tumour symposium: laying the foundations for future consensus","volume":"7","author":"Murray","year":"2013","journal-title":"Ecancermedicalscience"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2008\u20130037","article-title":"Pediatric central nervous system germ cell tumors: A review","volume":"13","author":"Echevarr\u00eda","year":"2008","journal-title":"Oncologist"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 who classification of tumors of the central nervous system: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-oncology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.4143\/crt.2016.129","article-title":"Nationwide population-based incidence and survival rates of Malignant central nervous system germ cell tumors in korea, 2005\u20132012","volume":"49","author":"Lee","year":"2017","journal-title":"Cancer Res Treat"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3181983af5","article-title":"Incidence patterns of central nervous system germ cell tumors: A seer study","volume":"31","author":"Goodwin","year":"2009","journal-title":"J Pediatr hematology\/oncology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not050","article-title":"Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implications","volume":"15","author":"Aizer","year":"2013","journal-title":"Neuro-oncology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1997.86.3.0446","article-title":"Primary intracranial germ cell tumors: A clinical analysis of 153 histologically verified cases","volume":"86","author":"Matsutani","year":"1997","journal-title":"J Neurosurg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1365-2265.2002.01620.x","article-title":"Suprasellar germ cell tumours: specific problems and the evolution of optimal management with a combined chemoradiotherapy regimen","volume":"57","author":"Janmohamed","year":"2002","journal-title":"Clin Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/0883073809342127","article-title":"Central nervous system germ cell tumors: classification, clinical features, and treatment with a historical overview","volume":"24","author":"Fujimaki","year":"2009","journal-title":"J Child Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102789","article-title":"Intracranial germinoma-association between delayed diagnosis, altered clinical manifestations, and prognosis","volume":"15","author":"Jab\u0142o\u0144ska","year":"2023","journal-title":"Cancers"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab242","article-title":"The Japan society for neuro-oncology guideline on the diagnosis and treatment of central nervous system germ cell tumors","volume":"24","author":"Nakamura","year":"2022","journal-title":"Neuro-oncology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab252","article-title":"Eano, sno and euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults","volume":"24","author":"Frappaz","year":"2022","journal-title":"Neuro-oncology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox122","article-title":"Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the siop-cns-gct-96 trial","volume":"19","author":"Calaminus","year":"2017","journal-title":"Neuro-oncology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019\u2013317245","article-title":"Symptom interval and treatment burden for patients with Malignant central nervous system germ cell tumours","volume":"105","author":"Hayden","year":"2020","journal-title":"Arch Dis childhood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.10.082","article-title":"Delays in diagnosis of pediatric histologically confirmed sellar germ cell tumors in China: A retrospective risk factor analysis","volume":"122","author":"Zhang","year":"2019","journal-title":"World Neurosurg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.06.024","article-title":"Delayed diagnosis in children with intracranial germ cell tumors","volume":"163","author":"Sethi","year":"2013","journal-title":"J Pediatr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.01.028","article-title":"Results of biopsy-proven sellar germ cell tumors: nine years' Experience in a single center","volume":"112","author":"Zhang","year":"2018","journal-title":"World Neurosurg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10143\u2013014-0544\u20138","article-title":"Long-term follow-up and quality of life in patients with intracranial germinoma","volume":"37","author":"Martens","year":"2014","journal-title":"Neurosurgical Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not127","article-title":"Neuropsychological functions and quality of life in survived patients with intracranial germ cell tumors after treatment","volume":"15","author":"Liang","year":"2013","journal-title":"Neuro-oncology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4158\/ep-2020\u20130192","article-title":"Pituitary dysfunction in patients with intracranial germ cell tumors treated with radiotherapy","volume":"26","author":"Xiang","year":"2020","journal-title":"Endocrine practice: Off J Am Coll Endocrinol Am Assoc Clin Endocrinologists"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2020.07.017","article-title":"Neurological and endocrinological manifestations of 49 children with intracranial pure germinoma at initial diagnosis in Taiwan","volume":"62","author":"Chang","year":"2021","journal-title":"Pediatr neonatology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20136736(16)30053\u20138","article-title":"Hypopituitarism","volume":"388","author":"Higham","year":"2016","journal-title":"Lancet (London England)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/erc-21\u20130381","article-title":"Precocious puberty due to intracranial germ cell tumors: A case-control study","volume":"29","author":"Chen","year":"2022","journal-title":"Endocrine-related Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016\u20132118","article-title":"Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0800459","article-title":"Clinical practice. Precocious puberty","volume":"358","author":"Carel","year":"2008","journal-title":"New Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.76.3268","article-title":"Endocrine late effects in childhood cancer survivors","volume":"36","author":"Chemaitilly","year":"2018","journal-title":"J Clin oncology: Off J Am Soc Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2023\u20130368","article-title":"Intracranial germ cell tumors: A view of the endocrinologist","volume":"36","author":"Tong","year":"2023","journal-title":"J Pediatr Endocrinol metabolism: JPEM"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.12.084","article-title":"Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy","volume":"84","author":"Odagiri","year":"2012","journal-title":"Int J Radiat oncology biology Phys"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s11060\u2013020-03642\u20131","article-title":"Long term toxicity of intracranial germ cell tumor treatment in adolescents and young adults","volume":"149","author":"Wong","year":"2020","journal-title":"J neuro-oncology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14740\/jem807","article-title":"Growth hormone deficiency in childhood intracranial germ cell tumor survivors","volume":"12","author":"Lone","year":"2022","journal-title":"J Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00432\u2013018-2743\u20130","article-title":"Treatment outcomes of intracranial germinoma: A retrospective analysis of 170 patients from a single institution","volume":"145","author":"Lian","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26564","article-title":"Change in treatment strategy for intracranial germinoma: long-term follow-up experience at a single institute","volume":"118","author":"Chen","year":"2012","journal-title":"Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1530\/eje-20\u20131310","article-title":"Recovery of hypothalamus-pituitary-gonadal dysfunction after the treatment of suprasellar germ cell tumors","volume":"184","author":"Zhang","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s11060\u2013014-1619\u20137","article-title":"Diabetes insipidus in pediatric germinomas of the suprasellar region: characteristic features and significance of the pituitary bright spot","volume":"121","author":"Kilday","year":"2015","journal-title":"J neuro-oncology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s12020\u2013022-03121\u20139","article-title":"Endocrine manifestations of paediatric intracranial germ cell tumours: from diagnosis to long-term follow-up","volume":"77","author":"Partenope","year":"2022","journal-title":"Endocrine"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1408065\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T05:12:47Z","timestamp":1718687567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1408065\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":36,"alternative-id":["10.3389\/fendo.2024.1408065"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1408065","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,18]]},"article-number":"1408065"}}